1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Univariate analysis
Variable mRS 0–2 mRS 3–6 P Value TICI score 0/1/2a 13.33% 86.67% .000329 2b/3 49.58% 50.42% BBBD No 50.98% 49.02% .095777 Yes 36.25% 63.75% Aggravation of lesions No 53.33% 46.67% .000021 Yes 11.76% 88.24% Hemorrhagic or complications at 24 hr No 49.06% 50.94% .002663 Yes 21.05% 78.95%
Note:—BBBD indicates blood-brain barrier disruption.